⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMVT News
Immunovant, Inc. Common Stock
Immunovant, Inc. (IMVT) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
IMVT
Immunovant Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Immunovant (IMVT)
prnewswire.com
IMVT
IMVT Investor Alert: Levi & Korsinsky Investigates Immunovant, Inc. (IMVT) For Potential Securities Fraud
accessnewswire.com
IMVT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immunovant, Inc. (IMVT) And Encourages Investors to Reach Out
accessnewswire.com
IMVT
IMVT SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Immunovant, Inc. For Possible Securities Law Violations
accessnewswire.com
IMVT
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
globenewswire.com
IMVT
ROIV
Global Lupus Nephritis Market to Reach USD 4.08 Billion by 2034 at 8.5% CAGR as Rising Disease Burden and Breakthroughs in Targeted Therapies Accelerate Market Expansion, Says Maximize Market Research
prnewswire.com
PFE
AZN
MRK
BMY
GSK
AMGN
BIIB
JNJ
VRTX
IMVT
ABBV
LLY
SNY
REGN
GILD
BHC
AUR
UCB
Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight
prnewswire.com
VBIO
AMGN
JNJ
BMY
IMVT
Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation
globenewswire.com
IMVT
ABBV
PFE
Form 8-K
sec.gov
IMVT